Eagle Global Advisors LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,415 shares of the healthcare conglomerate’s stock after purchasing an additional 394 shares during the quarter. Eagle Global Advisors LLC’s holdings in UnitedHealth Group were worth $448,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Candriam Luxembourg S.C.A. raised its holdings in UnitedHealth Group by 15.0% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 168,372 shares of the healthcare conglomerate’s stock worth $27,616,000 after purchasing an additional 21,943 shares during the period. CAPROCK Group Inc. raised its holdings in UnitedHealth Group by 13.1% in the 1st quarter. CAPROCK Group Inc. now owns 6,243 shares of the healthcare conglomerate’s stock worth $1,024,000 after purchasing an additional 724 shares during the period. Van Cleef Asset Management Inc raised its holdings in UnitedHealth Group by 4.0% in the 1st quarter. Van Cleef Asset Management Inc now owns 11,121 shares of the healthcare conglomerate’s stock worth $1,824,000 after purchasing an additional 425 shares during the period. Mn Services Vermogensbeheer B.V. raised its holdings in UnitedHealth Group by 3.9% in the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock worth $3,946,000 after purchasing an additional 970 shares during the period. Finally, NBW Capital LLC acquired a new position in UnitedHealth Group in the 1st quarter worth about $4,360,000. 86.21% of the stock is owned by institutional investors.

A number of equities analysts recently weighed in on the company. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $205.00 price target on shares of UnitedHealth Group in a report on Friday, July 7th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $200.00 price target (up previously from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Citigroup Inc. upped their price target on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $212.00 price target on shares of UnitedHealth Group in a report on Thursday, July 20th. One investment analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $203.41.

ILLEGAL ACTIVITY WARNING: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/16/eagle-global-advisors-llc-has-448000-position-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Incorporated (UNH) opened at 198.18 on Friday. The company has a 50-day moving average price of $195.28 and a 200 day moving average price of $180.64. UnitedHealth Group Incorporated has a 12 month low of $133.03 and a 12 month high of $200.76. The stock has a market capitalization of $191.61 billion, a price-to-earnings ratio of 23.81 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue was up 7.7% on a year-over-year basis. During the same period last year, the firm posted $1.96 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.51%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is presently 35.13%.

In related news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 25,600 shares of company stock valued at $4,962,694. Company insiders own 0.89% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.